Glenmark Pharma FY09 cons net profit at Rs 193.5 crore
July 14, 2009 – 12:03 am | 1 views
|
Glenmark Pharma has declared its FY09 results. The consolidated revenues were up 6% at Rs 2,121.54 crore.
Its consolidated net profit was at Rs 193.5 crore versus Rs 632.1 crore.
Its net profit numbers not comparable.
Q4FY09
Glenmark’s Q4 net sales declined 14% to Rs 491 crore versus Rs 573 crore. Operating loss stood at Rs 43 crore versus operating profit of Rs 223 crore. The company posted net loss of Rs 121 crore in Q4 as against profit of Rs 219 crore in Q4FY08.
Other factors:
Business grew by 21% excluding outlicensing revenue.
Glenmark to pay Rs 0.40 per share dividend.
Tags: about-us, Brokerage Recos, BSE Codes, glenmark pharma, latest results, Latest Results, Live Calls, Market News, microsoft, nifty-levels, nse, standalone net sales
